The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.
Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates, and they ...
It's too soon to know if the trend will last. But health providers fear the national discourse around vaccines could yield more sickness and death this winter.
A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...
A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...
The FDA has informed Merck, Sanofi and AstraZeneca of the safety investigation into their RSV antibodies, though it remains ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
The global respiratory syncytial virus vaccines market size was calculated at USD 3.55 billion in 2024 and is expected to grow steadily from USD 5.05 billion in 2025 to reach around USD 120.86 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback